Tyvaso (treprostinil)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
June 2016
WARNINGS AND PRECAUTIONS
Risk of Bleeding
(Add) Tyvaso inhibits platelet aggregation and increases the risk of...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts